Safety and Efficacy of Midline and PICC

  • End date
    May 10, 2022
  • participants needed
  • sponsor
    Centre hospitalier de l'Université de Montréal (CHUM)
Updated on 31 August 2021


The purpose of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter.


Vascular access devices (VADs), including peripherally inserted central venous catheters (PICCs) remain a cornerstone for the delivery of necessary intravenous therapy. PICCs are being selected for venous access more frequently today than ever before.

The advantage of PICC is that it can be used for all intravenous therapy. However, PICC requires the use of fluoroscopy or other type of guidance which add to the cost and time required to insert the catheter. Midline, on the other hand, can be inserted under ultrasound guidance, takes less time to be inserted and cost less than PICC insertion.

Despite lower cost and better accessibility of midline in comparison with PICC for non-vesicant intravenous therapy, there is very little evidence in the literature to suggest that one type of venous access is better than the other.

The primary objective of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter.

Results of this trial will allow improving a quality of evidence for using midline instead of PICC for specified indications. If Midline are non-inferior for some indications, they would represent a more accessible and less expensive alternative than PICC insertion.

Condition Metastatic Triple-Negative Breast Cancer, Chronic Diarrhea, Skin Wounds, Chronic Shoulder Pain, Injection Port, Peripheral Arterial Occlusive Disease, Brain Function, Primary Immunodeficiency, Near-Sighted Corrective Surgery, Central Venous Catheter, Breast Cancer - HER2 Positive, Diet and Nutrition, Razor Bumps (Pseudofolliculitis Barbae), Vaginal Atrophy, Anal Dysplasia, Vascular Access Devices, Recurrent Respiratory Papillomatosis, Pediatric Health, Adverse Effects, Drugs
Treatment Bard PowerPICC, Bard PowerMidline catheter
Clinical Study IdentifierNCT03502980
SponsorCentre hospitalier de l'Université de Montréal (CHUM)
Last Modified on31 August 2021


Yes No Not Sure

Inclusion Criteria

Required intra venous therapy
Expected duration of the venous access: > 6 days and < 30days

Exclusion Criteria

Patient has a contraindication to insertion of either a Midline or a PICC relative to the therapy
Patient from other hospitals who come to the CHUM only for the installation of a central line
Decreased cognitive ability to care for device at home
Preexisting bacteremia (ie, existing positive blood cultures that had not been repeated with negative results)
Preexisting venous thrombosis or known hypercoagulable states (such as protein C or S deficiency, antithrombin deficiency, lupus anticoagulant)
End-stage renal disease requiring vein preservation
Venous access with multiple lumens required
Patients not able to give informed consent
Prior participation to this study
Patient is enrolled in another investigational study
Patients hospitalized in the intensive care unit
Patients who are difficult to puncture and require multiple blood samples
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note